COMPANY
Keywords: small molecule neurology neurodegenerative diseases Lewy body dementia frontotemporal dementia and/or amyotrophic lateral sclerosis 7
Location: Boston, MA · source · Oct 14, 2026
Profile checked Oct 10, 2026
Timeline
- Partnership Partnership / licensing announced Aug 4, 2026. Source: SEC filing. source ↗
- Raise Private placement: $10.5M (total, as published), announced Jun 10, 2026. Source: SEC filing. source ↗
Funding
Raised: $10.5M. Last 2 years.
- Private placement: $10.5M (total, as published), announced Jun 10, 2026. Source: SEC filing. source ↗
- Partnership / licensing announced Aug 4, 2026. Source: SEC filing. source ↗